First National Trust Co lifted its stake in Bain Capital Specialty Finance, Inc. (NYSE:BCSF - Free Report) by 189.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 91,690 shares of the company's stock after acquiring an additional 60,024 shares during the period. First National Trust Co owned approximately 0.14% of Bain Capital Specialty Finance worth $1,522,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of BCSF. Janney Montgomery Scott LLC grew its stake in shares of Bain Capital Specialty Finance by 28.7% in the first quarter. Janney Montgomery Scott LLC now owns 68,202 shares of the company's stock worth $1,069,000 after acquiring an additional 15,196 shares during the last quarter. Advisors Asset Management Inc. boosted its stake in Bain Capital Specialty Finance by 13.9% during the first quarter. Advisors Asset Management Inc. now owns 109,744 shares of the company's stock worth $1,721,000 after buying an additional 13,397 shares in the last quarter. Lazard Asset Management LLC boosted its stake in Bain Capital Specialty Finance by 58.5% during the first quarter. Lazard Asset Management LLC now owns 12,410 shares of the company's stock worth $194,000 after buying an additional 4,581 shares in the last quarter. Mount Yale Investment Advisors LLC boosted its stake in Bain Capital Specialty Finance by 1.0% during the first quarter. Mount Yale Investment Advisors LLC now owns 86,851 shares of the company's stock worth $1,362,000 after buying an additional 898 shares in the last quarter. Finally, Virtus Investment Advisers Inc. boosted its stake in Bain Capital Specialty Finance by 25.4% during the first quarter. Virtus Investment Advisers Inc. now owns 15,041 shares of the company's stock worth $236,000 after buying an additional 3,048 shares in the last quarter.
Bain Capital Specialty Finance Price Performance
Shares of NYSE BCSF traded up $0.17 during midday trading on Wednesday, reaching $16.93. 161,556 shares of the company traded hands, compared to its average volume of 234,619. The stock's 50-day simple moving average is $16.80 and its 200-day simple moving average is $16.59. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.41 and a current ratio of 1.41. Bain Capital Specialty Finance, Inc. has a 12 month low of $14.75 and a 12 month high of $17.25. The firm has a market cap of $1.09 billion, a PE ratio of 8.50 and a beta of 1.13.
Bain Capital Specialty Finance (NYSE:BCSF - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.50 by $0.03. Bain Capital Specialty Finance had a return on equity of 11.90% and a net margin of 43.62%. The business had revenue of $72.54 million during the quarter. During the same period in the prior year, the firm earned $0.55 earnings per share. As a group, equities analysts anticipate that Bain Capital Specialty Finance, Inc. will post 2.06 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on BCSF shares. Wells Fargo & Company decreased their price target on shares of Bain Capital Specialty Finance from $18.00 to $17.00 and set an "overweight" rating on the stock in a research note on Thursday, August 8th. Keefe, Bruyette & Woods reissued a "market perform" rating and set a $17.00 price objective on shares of Bain Capital Specialty Finance in a report on Wednesday, August 21st.
Get Our Latest Research Report on BCSF
Bain Capital Specialty Finance Profile
(
Free Report)
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Further Reading
Before you consider Bain Capital Specialty Finance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bain Capital Specialty Finance wasn't on the list.
While Bain Capital Specialty Finance currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.